ClinicalTrials.Veeva

Menu

Creatine-Guanidinoacetic Acid Supplementation for Sarcopenia (CREGAAS)

U

University of Novi Sad, Faculty of Sport and Physical Education

Status

Completed

Conditions

Sarcopenia

Treatments

Other: Inulin
Dietary Supplement: Creatine-guanidinoacetic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT04652921
DS-04/2020

Details and patient eligibility

About

Sarcopenia-driven brain and muscle creatine deficit could be seen as a distinctive pathological facet of this condition, and this might be approached with targeted therapies in aim to restore creatine homeostasis in target tissues. Among potential therapeutic candidates, guanidinoacetate (GAA) appears recently as a direct precursor of creatine that may favorably upregulate muscle and brain creatine concentration. Interestingly, GAA-creatine mixture was found to be superior than creatine itself to effectively improves bioenergetics in the human brain and muscle in healthy humans, perhaps due to the unique transportability features of this combination. Here, we plan to evaluate does creatine-GAA supplementation affects various biomarkers of sarcopenia in elderly.

Enrollment

30 patients

Sex

All

Ages

65 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 70 years
  • Free of acute disorders

Exclusion criteria

  • History of dietary supplement use during the past 4 weeks

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups, including a placebo group

Creatine-guanidinoacetic acid
Experimental group
Description:
2 grams of creatine and 2 grams of GAA Administered one dose two times per day on an empty stomach in the morning and at the evening
Treatment:
Dietary Supplement: Creatine-guanidinoacetic acid
Inulin
Placebo Comparator group
Description:
4 grams of inulin Administered one dose two times per day on an empty stomach in the morning and at the evening
Treatment:
Other: Inulin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems